AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicGlucoseBlood GlucoseGlucose Tolerance TestGlucose IntoleranceClinical Trials, Phase III as TopicClinical Trials, Phase II as TopicTreatment OutcomeGlucose OxidaseGlucose Transporter Type 1Clinical Trials, Phase I as TopicResearch DesignDouble-Blind MethodGlucose Transporter Type 4Controlled Clinical Trials as TopicTime FactorsBlood Glucose Self-MonitoringMonosaccharide Transport ProteinsInsulinGlucose 1-DehydrogenaseRandomized Controlled Trials as TopicDeoxyglucoseDiabetes Mellitus, Type 2Patient SelectionGlucose Transporter Type 2Hypoglycemic AgentsPlacebosMulticenter Studies as TopicProspective StudiesFastingGlucose Transporter Type 3Clinical Trials Data Monitoring CommitteesFollow-Up StudiesGlycogenClinical ProtocolsClinical Trials, Phase IV as TopicNeoplasmsSingle-Blind MethodGlucagonGlucose DehydrogenasesDose-Response Relationship, DrugGlycolysisHypoglycemiaGluconeogenesisIslets of LangerhansLactatesLactic AcidAntineoplastic AgentsEarly Termination of Clinical TrialsDiabetes MellitusFructoseDrug Administration ScheduleDrug Therapy, CombinationHexokinaseBiological TransportLiverGlucose-6-PhosphateGlucokinaseAdministration, OralRisk FactorsPilot ProjectsGlucosephosphatesGlucose Metabolism DisordersFatty Acids, NonesterifiedHemoglobin A, Glycosylated3-O-MethylglucoseSample SizeCross-Over StudiesObesityInfusions, IntravenousMethylglucosidesPhlorhizinMuscle, SkeletalQuality of LifeUnited StatesKineticsEnergy MetabolismResearch SubjectsSeverity of Illness IndexReproducibility of ResultsBody WeightDietary CarbohydratesPostprandial PeriodOutcome Assessment (Health Care)Combined Modality TherapyHomeostasisC-PeptideGlycerolDiabetes Mellitus, ExperimentalEndpoint DeterminationCost-Benefit AnalysisAntineoplastic Combined Chemotherapy ProtocolsAdipose TissueSodium-Glucose Transporter 1Evidence-Based MedicineRandom AllocationInsulin-Secreting CellsDiabetes Mellitus, Type 1Analysis of VarianceSurvival Analysis